S&P 500   2,607.93 (+4.79%)
DOW   22,089.50 (+4.93%)
QQQ   192.28 (+4.86%)
AAPL   253.00 (+4.80%)
FB   160.69 (+4.22%)
MSFT   161.27 (+4.84%)
GOOGL   1,149.02 (+5.15%)
AMZN   1,956.90 (+2.64%)
CGC   13.80 (+4.15%)
NVDA   260.96 (+6.99%)
BABA   193.98 (+3.67%)
GE   7.08 (+5.05%)
TSLA   504.12 (+5.02%)
AMD   45.81 (+7.54%)
T   28.74 (+4.62%)
ACB   0.80 (-1.24%)
NFLX   370.60 (+2.44%)
BAC   20.82 (+3.94%)
GILD   76.67 (-1.97%)
DIS   96.82 (+3.13%)
S&P 500   2,607.93 (+4.79%)
DOW   22,089.50 (+4.93%)
QQQ   192.28 (+4.86%)
AAPL   253.00 (+4.80%)
FB   160.69 (+4.22%)
MSFT   161.27 (+4.84%)
GOOGL   1,149.02 (+5.15%)
AMZN   1,956.90 (+2.64%)
CGC   13.80 (+4.15%)
NVDA   260.96 (+6.99%)
BABA   193.98 (+3.67%)
GE   7.08 (+5.05%)
TSLA   504.12 (+5.02%)
AMD   45.81 (+7.54%)
T   28.74 (+4.62%)
ACB   0.80 (-1.24%)
NFLX   370.60 (+2.44%)
BAC   20.82 (+3.94%)
GILD   76.67 (-1.97%)
DIS   96.82 (+3.13%)
S&P 500   2,607.93 (+4.79%)
DOW   22,089.50 (+4.93%)
QQQ   192.28 (+4.86%)
AAPL   253.00 (+4.80%)
FB   160.69 (+4.22%)
MSFT   161.27 (+4.84%)
GOOGL   1,149.02 (+5.15%)
AMZN   1,956.90 (+2.64%)
CGC   13.80 (+4.15%)
NVDA   260.96 (+6.99%)
BABA   193.98 (+3.67%)
GE   7.08 (+5.05%)
TSLA   504.12 (+5.02%)
AMD   45.81 (+7.54%)
T   28.74 (+4.62%)
ACB   0.80 (-1.24%)
NFLX   370.60 (+2.44%)
BAC   20.82 (+3.94%)
GILD   76.67 (-1.97%)
DIS   96.82 (+3.13%)
S&P 500   2,607.93 (+4.79%)
DOW   22,089.50 (+4.93%)
QQQ   192.28 (+4.86%)
AAPL   253.00 (+4.80%)
FB   160.69 (+4.22%)
MSFT   161.27 (+4.84%)
GOOGL   1,149.02 (+5.15%)
AMZN   1,956.90 (+2.64%)
CGC   13.80 (+4.15%)
NVDA   260.96 (+6.99%)
BABA   193.98 (+3.67%)
GE   7.08 (+5.05%)
TSLA   504.12 (+5.02%)
AMD   45.81 (+7.54%)
T   28.74 (+4.62%)
ACB   0.80 (-1.24%)
NFLX   370.60 (+2.44%)
BAC   20.82 (+3.94%)
GILD   76.67 (-1.97%)
DIS   96.82 (+3.13%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Oncolytics BiotechAVEO PharmaceuticalsOramed PharmaceuticalsCatalyst BiosciencesSesen Bio
SymbolNASDAQ:ONCYNASDAQ:AVEONASDAQ:ORMPNASDAQ:CBIONASDAQ:SESN
Price Information
Current Price$1.47$3.77$3.10$4.18$0.54
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$9.00$14.83$10.83$25.00$2.25
% Upside from Price Target512.24% upside293.46% upside249.46% upside498.09% upside315.59% upside
Trade Information
Market Cap$53.78 million$55.80 million$56.55 million$45.42 million$58.30 million
Beta2.660.871.892.181.21
Average Volume689,586258,370127,037237,5071,305,650
Sales & Book Value
Annual RevenueN/A$28.80 million$2.70 million$10,000.00$430,000.00
Price / SalesN/A2.1020.485,049.44138.49
CashflowN/A$0.63 per share$0.86 per shareN/AN/A
Price / CashN/A5.973.61N/AN/A
Book ValueN/A$0.92 per share$1.12 per share$5.68 per share($0.26) per share
Price / BookN/A4.102.770.74-2.08
Profitability
Net Income$-24,960,000.00$9.39 million$-14,350,000.00$-55,180,000.00$-107,500,000.00
EPS($0.70)$0.61$0.82($4.60)($0.39)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A32.60%-297.30%N/AN/A
Return on Equity (ROE)-649.95%225.40%-38.51%-63.32%-527.20%
Return on Assets (ROA)-123.08%21.03%-22.16%-54.75%-32.97%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%0.42%N/A0.02%N/A
Current Ratio1.47%2.40%6.62%3.32%6.39%
Quick Ratio1.47%2.40%6.62%3.32%6.39%
Ownership Information
Institutional Ownership Percentage1.06%N/A3.34%62.59%17.24%
Insider Ownership Percentage0.10%4.20%20.50%4.59%2.00%
Miscellaneous
EmployeesN/A17N/A2124
Shares Outstanding37.09 million16.08 million17.84 million12.08 million109.99 million
Next Earnings Date5/7/2020 (Estimated)5/14/2020 (Estimated)4/8/2020 (Estimated)5/7/2020 (Estimated)5/11/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel